GILD241115P95000
- 6.55
- +4.00+156.86%
Gilead Sciences Newsroom
Weekly Buzz: Not All Parties Last Forever
Market Falls to End All-Time High Week | Wall Street Today
Express News | Shares of Pharmaceutical and Healthcare Stocks Are Trading Lower. The Sector Has Been Under Pressure After President-elect Trump Nominated Robert F. Kennedy Jr. to Lead the HHS
Large Pharmas, Biotechs Down as Industries Grapple With RFK Jr. at HHS
U.S. Pharma Is Largely Immune From 'MAHA' Impact: Wolfe
Gilead Unveils Long-Term Data From Seladelpar In Patients With Rare Liver Disease
Gilead on Pace for Largest Percent Decrease Since February -- Data Talk
Gilead Sciences Says Most of Phase 3 Primary Biliary Cholangitis Participants Treated With Livdelzi Achieved Biochemical Response
Market Falls Friday After Light Earnings and 13F's | Live Stock
Express News | Gilead Sciences Inc - No Treatment-Related Serious Adverse Events Reported for Livdelzi
Express News | Gilead Sciences Inc - Livdelzi Shows 81% Efficacy in Phase 3 Assure Study
Express News | Gilead’s Livdelzi (Seladelpar) Demonstrated a Sustained Efficacy and Long-Term Safety Profile in Management of Primary Biliary Cholangitis
Trump's Victory Spurs $50B Corporate Bond Surge As Tax Cut Optimism Drives Borrowing Costs To 25-Year Low
Gilead Sciences Initiated at Outperform by Wolfe Research
Vaccines stocks in the usa collectively plummet! Trump surprisingly appoints an anti-vaccine advocate as the Secretary of Health in the usa.
① Trump nominated Robert F. Kennedy Jr. as the new Secretary of Health and Human Services, which triggered a sell-off in vaccine companies; ② Kennedy advocates very radical views, opposing vaccines since 2005, and questioning the transparency of the usa government in public health information.
Market Falls Thursday, Powell Said Fed Will Take Things Slow | Wall Street Today
Wolfe Research Maintains Gilead Sciences(GILD.US) With Buy Rating, Raises Target Price to $110
Gilead, Vertex Initiated as New Big Biotech Buys at Citi
Thursday Market Chills From Election Celebration | Live Stock
Gilead Sciences, Inc. (GILD) Is Attracting Investor Attention: Here Is What You Should Know